Area of research
Immunology · Epidemiology
Research interest
Research interests include Immune Cell Function and Interaction, T-cell and B-cell Immunology, Reproductive System and Pregnancy, and Liver Disease Diagnosis and Treatment.
Host Plasma Microenvironment in Immunometabolically Impaired HIV Infection Leads to Dysregulated Monocyte Function and Synaptic Transmission <i>Ex Vivo</i>
Transient tissue residency and lymphatic egress define human CD56bright NK cell homeostasis
High-dimensional single-cell analysis of human natural killer cell heterogeneity
IL-1β promotes adipogenesis by directly targeting adipocyte precursors
Chemogenomic Screening in a Patient‐Derived 3D Fatty Liver Disease Model Reveals the CHRM1‐TRPM8 Axis as a Novel Module for Targeted Intervention
Immunobiology of primary sclerosing cholangitis
Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia
SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19
Role of bacteria and microbial metabolites in immune modulation during early life
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
Evasion of neutralising antibodies by omicron sublineage BA.2.75
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells
Bile from Patients with Primary Sclerosing Cholangitis Contains Mucosal-Associated Invariant T-Cell Antigens
Natural killer cells in antiviral immunity
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
Continuous human uterine NK cell differentiation in response to endometrial regeneration and pregnancy
High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19
A biliary immune landscape map of primary sclerosing cholangitis reveals a dominant network of neutrophils and tissue-resident T cells
Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C
SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Natural killer cell immunotypes related to COVID-19 disease severity
MAIT cell activation and dynamics associated with COVID-19 disease severity
The Identity of Human Tissue-Emigrant CD8+ T Cells
Innate lymphoid cell composition associates with COVID‐19 disease severity
Cytokines regulate the antigen-presenting characteristics of human circulating and tissue-resident intestinal ILCs
MAIT Cells Are Enriched and Highly Functional in Ascites of Patients With Decompensated Liver Cirrhosis
Reversal of Immunity After Clearance of Chronic HCV Infection—All Reset?
The tumour microenvironment and immune milieu of cholangiocarcinoma